| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/29/1993 | WO1993000365A3 Hepatitis c virus (hcv) polypeptides |
| 04/29/1993 | DE4135543A1 Rekombinantes core-streptavidin Recombinant core streptavidin |
| 04/29/1993 | DE4134814A1 Neues thrombininhibitorisches protein aus zecken Tick novel thrombin protein from |
| 04/29/1993 | CA2121493A1 Bacterial expression vectors containing dna encoding secretion signals of lipoproteins |
| 04/29/1993 | CA2121137A1 Use of thiol redox proteins for reducing disulfide bonds |
| 04/29/1993 | CA2121127A1 Lymphokine gene therapy of cancer |
| 04/29/1993 | CA2120507A1 Soluble variants of type 1 membrane proteins, and methods of using them |
| 04/29/1993 | CA2120050A1 Virulence associated proteins in borrelia burgdorferi (bb) |
| 04/28/1993 | EP0539167A2 Peg imidates and protein derivatives thereof |
| 04/28/1993 | EP0539140A1 Lyophilized acidic fibroblast growth factor |
| 04/28/1993 | EP0539087A1 Stabilized topical acidic fibroblast growth factor formulation |
| 04/28/1993 | EP0538952A1 Antitumor Vaccines Comprising IL-6 Transfected Cells |
| 04/28/1993 | EP0538951A2 A method for preparing a thromboplastin reagent from cultured cells that is suitable for use in the prothrombin time test |
| 04/28/1993 | EP0538463A1 Novel biologically active peptide compositions and uses therefor |
| 04/28/1993 | EP0538459A1 Phospholipid-targeted thrombolytic agents |
| 04/28/1993 | EP0538430A1 Endometrial antigen, composition, test kit and method for endometrial antibody determination |
| 04/28/1993 | EP0538412A1 A cDNA ENCODING THE RAT D 1? DOPAMINE RECEPTOR LINKED TO ADENYLYL CYCLASE ACTIVATION AND EXPRESSION PRODUCT |
| 04/28/1993 | EP0538404A1 Fibroblast growth factor receptors |
| 04/28/1993 | EP0538401A1 Novel receptor-type phosphotyrosine phosphatase |
| 04/28/1993 | EP0538399A1 Cyclic cell adhesion modulation compounds |
| 04/28/1993 | EP0538398A1 Tissue-derived tumor growth inhibitors, methods for preparation and uses thereof |
| 04/28/1993 | EP0538396A1 Inhibitors of retroviral proteases |
| 04/28/1993 | EP0538395A1 Nucleic acid sequences encoding a human dopamine d 1? receptor |
| 04/28/1993 | EP0538383A1 Inhibitors of aspartic proteases |
| 04/28/1993 | EP0538374A1 Aspartic protease inhibitors |
| 04/28/1993 | EP0538371A1 Streptomyces vectors for production of heterologous proteins |
| 04/28/1993 | EP0538366A1 Retroviral protease inhibitors |
| 04/28/1993 | EP0538318A1 Production of outer membrane (om) proteins in gram-positive bacteria and recovery of protective epitopes |
| 04/28/1993 | EP0538300A1 O-glycosylated ifn-alpha. |
| 04/28/1993 | EP0538273A1 Alveolar surfactant proteins |
| 04/28/1993 | EP0527763A4 Method to purify basic fibroblast growth factor |
| 04/28/1993 | EP0524254A4 A binary genetic system to control expression of a transgene in a transgenic animal |
| 04/28/1993 | EP0507852A4 Gene deleted in colorectal cancer of humans |
| 04/28/1993 | EP0499625A4 Conglutinin fragments, their production and use |
| 04/28/1993 | EP0485530A4 Tgf--g(b) protein compositions for inhibition of cell proliferation |
| 04/28/1993 | EP0467992A4 Process for purifying a protein |
| 04/28/1993 | EP0453456B1 Pdgf-a, pdgf-aa, pdgf-ab, process for producing them and drugs containing them |
| 04/28/1993 | EP0403601B1 Novel somatotropins |
| 04/28/1993 | CN1071512A Method and reagents for hepatitis c detection |
| 04/28/1993 | CN1071333A Calcium receptor active molecules |
| 04/27/1993 | US5206384 Actinonin derivatives and pharmaceutically acceptable salts thereof |
| 04/27/1993 | US5206354 Dna sequence encoding active fragment of fibroblast growth factor, hbf-2 |
| 04/27/1993 | US5206353 Viricides |
| 04/27/1993 | US5206352 Compositions for clones containing DNA sequences associated with multidrug resistance in human cells |
| 04/27/1993 | US5206345 Binding specifically to epitope of cell surface; monoclonal antibodies and antigen-binding fragments |
| 04/27/1993 | US5206166 Genes encoding lepidopteran-active toxins and transformed hosts |
| 04/27/1993 | US5206164 Diagnosis of hepatocellular carcinoma and teratocarcinoma |
| 04/27/1993 | US5206163 Dna sequences; useful for vaccines, therapy, diagnostics |
| 04/27/1993 | US5206160 Composition containing buf-3 and superoxide dismutase as a cell cleavage promoting agent |
| 04/27/1993 | US5206154 Genetic sequence coding for polypeptide which suppresses bactericidal effect of cecropin linked to sequence coding for cecropin |
| 04/27/1993 | US5206153 Method of producing human α-fetoprotein and product produced thereby |
| 04/27/1993 | US5206152 Cloning and expression of early growth regulatory protein genes |
| 04/27/1993 | US5206142 Entamoeba histolytica diagnostic assay |
| 04/27/1993 | US5206086 Particle-stabilized epitopes for standardization and control of immunoassays |
| 04/27/1993 | US5206017 Reducing loss of glycosaminoglycans in connective tissue |
| 04/27/1993 | US5206014 Activating antibody response |
| 04/27/1993 | CA1317069C2 Synthetic peptides having pituitary growth hormone releasing activity |
| 04/27/1993 | CA1317068C Peptides influencing diuresis and natriuresis, a process for their preparation, agents containing them, and their use |
| 04/27/1993 | CA1317067C2 Process for their resolution of racemates of optically active bicyclic imino-o-carboxylic esters, and the use of the compounds thus obtainable for the synthesis of carboxyalkyl-dipeptides |
| 04/27/1993 | CA1316849C Vaccinia dna |
| 04/27/1993 | CA1316819C Insulin preparations containing magnesium ions |
| 04/27/1993 | CA1316746C Livestock feeding |
| 04/26/1993 | CA2081050A1 Treponema hyodysenteriae vaccine |
| 04/22/1993 | DE4134297A1 Monoclonal antibody specific for Mycoplasma pneumoniae |
| 04/22/1993 | CA2080891A1 Peg imidates and protein derivatives thereof |
| 04/22/1993 | CA2080538A1 Lyophilized acidic fibroblast growth factor |
| 04/22/1993 | CA2080537A1 Stabilized topical acidic fibroblast growth factor formulation |
| 04/21/1993 | EP0538230A1 Method for producing synthetic N-linked glycoconjugates |
| 04/21/1993 | EP0538030A2 Novel neutrophil activating factors |
| 04/21/1993 | EP0537722A2 Porcane liver polypeptides for treating viral infections |
| 04/21/1993 | EP0537634A2 Iron complexes containing conalbumin and its derivatives |
| 04/21/1993 | EP0537626A1 Diagnostic reagent for hepatitis C |
| 04/21/1993 | EP0537553A2 Farnesyl pyrophosphate synthetase and DNA sequence encoding the same |
| 04/21/1993 | EP0537497A2 Monoclonal antibodies against mycoplasma pneumoniae, hybridomas producing it, process for preparing them and their application |
| 04/21/1993 | EP0537489A1 Monoclonal antibodies against tumor-associated antigens, method for their preparation and their use |
| 04/21/1993 | EP0537399A1 A novel ribonuclease and its inhibitor |
| 04/21/1993 | EP0537326A1 Rna delivery vector |
| 04/21/1993 | EP0537318A1 New non-hygroscopic mono-ammonium salts. |
| 04/21/1993 | EP0537293A1 Ligand for cd28 receptor on b cells and methods |
| 04/21/1993 | EP0537276A1 Cancer-associated scm-recognition factor, preparation and method of use |
| 04/21/1993 | EP0537232A1 Recombinant pigeon pox virus vaccine |
| 04/21/1993 | EP0537199A1 Compositions for treating hiv-type 1 infection |
| 04/21/1993 | EP0537185A1 An enzymatic process for the preparation of derivatives of growth hormone releasing factor and peptides useful as intermediates in the process |
| 04/21/1993 | EP0537173A1 Cloning by complementation and related processes |
| 04/21/1993 | EP0537171A1 Cd46 variants |
| 04/21/1993 | EP0537166A1 Water-soluble polypeptides having high affinity for interferons alpha and beta |
| 04/21/1993 | EP0537163A1 Transformation of plants with non-structural plant virus gene sequences |
| 04/21/1993 | EP0537160A1 Expression of recombinant hemoglobin in yeast |
| 04/21/1993 | EP0537155A1 PURIFIED RAP GAPs, RAP GAP SEQUENCES, AND USES THEREOF |
| 04/21/1993 | EP0476038B1 Chemical products |
| 04/21/1993 | EP0407401B1 Human relaxin formulation |
| 04/21/1993 | EP0343248B1 Novel polypeptide and method for preparing the same |
| 04/21/1993 | EP0323997B1 Recombinant dna expression vectors |
| 04/21/1993 | EP0207165B1 Polypeptide secretion-causing vector, microorganisms transformed by said vector, and process for preparing polypeptide using said microorganisms |
| 04/20/1993 | US5204449 Carriers; drug delivery; veterinary medicine; target specificity; antifertility agents; animal growth regulators monoclonal antibodies; vaccines |
| 04/20/1993 | US5204446 Polypeptide having immunoreactivity with antibody specific to hepatitis b virus |
| 04/20/1993 | US5204445 Peptides and antibodies that inhibit integrin-ligand binding |
| 04/20/1993 | US5204328 N-methylated analogs of atriopeptin having increased potency and metabolic stability; hypotensive agents; vasodilation; congestive heart failure; renal hypertension |
| 04/20/1993 | US5204327 Treatment of cerebral edema with anp pharmaceutical compositions |
| 04/20/1993 | US5204326 Analgesics, antiulcer agents, lowering calcium absorption |